GlaxoSmithKline S.A.E (EGX:BIOC)
39.56
+0.31 (0.79%)
At close: Mar 27, 2025
GlaxoSmithKline S.A.E Revenue
In the year 2024, GlaxoSmithKline S.A.E had annual revenue of 2.99B EGP with 33.51% growth. GlaxoSmithKline S.A.E had revenue of 847.49M in the quarter ending December 31, 2024, with 27.74% growth.
Revenue
2.99B
Revenue Growth
+33.51%
P/S Ratio
1.09
Revenue / Employee
3.74M
Employees
800
Market Cap
3.26B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.99B | 750.60M | 33.51% |
Dec 31, 2023 | 2.24B | 416.99M | 22.87% |
Dec 31, 2022 | 1.82B | 11.19M | 0.62% |
Dec 31, 2021 | 1.81B | -180.79M | -9.07% |
Dec 31, 2020 | 1.99B | 288.80M | 16.95% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Commercial International Bank Egypt (CIB) S.A.E. | 114.75B |
El Sewedy Electric Company | 231.98B |
Talaat Moustafa Group Holding | 42.67B |
Eastern Company S.A.E | 30.98B |
Misr Fertilizer Production Company | 19.65B |
Egypt Aluminum | 40.94B |
Abu Qir Fertilizers and Chemical Industries Co. (S.A.E.) | 20.16B |
Qatar National Bank | 42.70B |